ArticleCureus2025
Recurrent Pericarditis in a Patient With Ankylosing Spondylitis: A Report of a Rare Case.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HLA-B27 and Constrictive Pericarditis: A Signal Worth Following.JACC. Case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Only a small subset of patients with ankylosing spondylitis (AS) develop cardiac complications, and pericardial inflammation is particularly uncommon. We report a 31-year-old human leukocyte antigen B27 (HLA-B27)-positive man with AS diagnosed in 2018 who, after discontinuing golimumab in 2021, experienced two episodes of acute pericarditis in 2025. In March, he presented with fever and chest pain. The electrocardiogram (ECG) showed diffuse, mild concave ST-segment elevation; chest computed tomography (CT) demonstrated a circumferential pericardial effusion measuring 24 mm with bilateral pleural effusions, consistent with polyserositis, and transthoracic echocardiography (TTE) confirmed a 15-17 mm fibrinous effusion without tamponade. He improved with colchicine and a corticosteroid taper. In August, he returned with pleuritic chest pain; the ECG revealed sinus tachycardia with diffuse ST elevation and PR-segment depression, and echocardiography showed a thin residual effusion. Bacterial and viral infections (including multiplex testing for respiratory and enteroviral pathogens and serology for cytomegalovirus, Epstein-Barr virus, and parvovirus B19), HIV, hepatitis B and C, and autoimmune causes were systematically excluded, and there were no clinical or imaging features to suggest malignancy. Taken together, the relapse and overall context favored attribution to AS-related inflammation. This case underscores the need to keep pericarditis in mind when patients with AS present with chest pain and to align pericarditis therapy with control of the underlying disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.